Exhibit 99.1
NEWSRELEASETranscat, Inc. • 35 Vantage Point Drive • Rochester, NY 14624 • 585-352-7777
IMMEDIATE RELEASE
Transcat Reports Record Revenue and Adjusted Earnings Per Share forFourth Quarter and Full Year Fiscal 2022
●Consolidated fourth quarter revenue of $55.9 million up 14.6% from prior year; full fiscal year revenue up 18.2% and surpassed the $200 million milestone
● ... (continue reading...)NASDAQ: AGRX 1 NASDAQ: AGRX Agile Therapeutics Corporate Presentation May 2022
NASDAQ: AGRX Forward - Looking Statements Certain information contained in this presentation and other matters discussed today or answers that may be given in response to questions may include “forward - looking statements.” We may, in some cases, use terms such as “predicts,” “believes,” “potential, ” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,”... (continue reading...)
Exhibit 99.1
NASDAQ: ABUS www.arbutusbio.com May 24, 2022 Corporate Presentation
Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the U . S . Private Securities Litigation Reform Act of 1995 and Canadian securities laws . All statements that are not historical facts are hereby identified as forward - looking statements for this purpose and include, among others, statements... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K AERIE PHARMACEUTICALS For: May 24
-
Form 6-K Ituran Location & Contro For: May 24
-
Form NPORT-P SCHWARTZ INVESTMENT TRUS For: Mar 31
-
Form NPORT-P SCHWARTZ INVESTMENT TRUS For: Mar 31
-
Form NPORT-P SCHWARTZ INVESTMENT TRUS For: Mar 31
-
Form 8-K TALOS ENERGY INC. For: May 24
-
Form 6-K TRANSALTA CORP For: May 24
-
Form 425 Oaktree Acquisition Corp Filed by: Alvotech
-
Form 6-K Yatsen Holding Ltd For: May 24
-
Form D/A Clover Biopharmaceutical
-
Form 8-K Aldeyra Therapeutics, For: May 24
-
Form 24F-2NT Invesco Senior Loan Fund For: Feb 28
-
Form 8-K Avalo Therapeutics, Inc. For: May 18
-
Form 8-K Citi Trends Inc For: May 24
-
Form 8-K WESTINGHOUSE AIR BRAKE For: May 18
-
Form 8-K NextPlay Technologies For: May 24
-
Form 8-K AVROBIO, Inc. For: May 24
-
Form 4 RumbleOn, Inc. For: May 23 Filed by: Dixon Denmar John
-
Form 8-K SIGMA LABS, INC. For: May 24
-
Form 8-K BEST BUY CO INC For: May 24
-
Form 6-K GILAT SATELLITE NETWORKS For: May 24
-
Form 6-K Burford Capital Ltd For: May 24
-
Form 4 VOXX International Corp For: May 23 Filed by: Kahli Beat
-
Form 4 MANHATTAN BRIDGE CAPITAL For: May 23 Filed by: JACKSON MICHAEL
-
Form 253G2 East Bay Permanent Real
-
Form 8-K AUTOZONE INC For: May 24
-
Form MA/A TIAA-CREF Tuition Financ
-
Form 6-K Youdao, Inc. For: May 24
-
Form 6-K AVINO SILVER & GOLD MINE For: May 24
-
Form 6-K VIA optronics AG For: May 24
-
Form SD ABB LTD
-
Form 6-K Affimed N.V. For: May 24
-
Form 20FR12B/A IPERIONX Ltd
-
Form 6-K NetEase, Inc. For: May 24
-
Form N-CSR SIT MUTUAL FUNDS II INC For: Mar 31
-
Form 6-K Ituran Location & Contro For: May 24
-
Form N-CSR SIT U S GOVERNMENT SECUR For: Mar 31
-
Form 6-K GFL Environmental Inc. For: May 24
-
Form 6-K ATRenew Inc. For: May 24
-
Form S-8 POS NOMURA HOLDINGS INC
-
Form SC 14D9/A ANTARES PHARMA, INC. Filed by: ANTARES PHARMA, INC.
-
Form 6-K SEQUANS COMMUNICATIONS For: Dec 31
-
Form 6-K HUTCHMED (China) Ltd For: May 24
-
Form S-8 POS NOMURA HOLDINGS INC
-
Form 497AD Eagle Point Income Co
-
Form 497AD Eagle Point Credit Co
-
Form 6-K PETROBRAS - PETROLEO For: Jun 30
-
Form DEFA14A DAVITA INC.
-
Form S-8 NOMURA HOLDINGS INC
-
Form SC TO-T/A ANTARES PHARMA, INC. Filed by: HALOZYME THERAPEUTICS, INC.